Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 30315-46-9 | MDL No. : | MFCD00190165 |
Formula : | C7H17NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JWBMVCAZXJMSOX-LURJTMIESA-N |
M.W : | 147.22 | Pubchem ID : | 2733671 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 40.93 |
TPSA : | 52.49 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.57 cm/s |
Log Po/w (iLOGP) : | 1.89 |
Log Po/w (XLOGP3) : | -0.52 |
Log Po/w (WLOGP) : | -0.27 |
Log Po/w (MLOGP) : | 0.08 |
Log Po/w (SILICOS-IT) : | 0.01 |
Consensus Log Po/w : | 0.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.16 |
Solubility : | 102.0 mg/ml ; 0.69 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.11 |
Solubility : | 113.0 mg/ml ; 0.769 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.83 |
Solubility : | 21.8 mg/ml ; 0.148 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.6% | With potassium tert-butylate; In tert-butyl alcohol; for 1.0h;Heating / reflux; | A mixture of (S)- (-)-3- (3-TERT-BUTYLAMINO)-1, 2-propanediol, (2. 0g, 13.59 mole) and 3, 4-DICHLORO-L, 2,5-thiadiazole (2. 11G, 13.59 mole) in anhydrous tert- butanol (10 ML) was heated to reflux under nitrogen. Potassium tert-butoxide solution in tert-butanol (1.0 M, 13.6 mL, 13.6 MMOLE) was then added and the mixture was refluxed for 60 min. The mixture was cooled to room temperature and filtered. The filtrate was concentrated to give brown-red oil (3.49 g, yield 96.6%). Purity by LC was 93.2% at 254 nm. MS (ESI, %): M/Z = 266 (M+1, 100) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
a. 30 g of (R)-glyceraldehyde, 36 cc of tert. butylamine in 800 cc of ethanol are hydrogenated over 8 g of 10 % palladium/carbon with H2 for 4 hours, the catalyst is filtered off and the solution is concentrated. (S)-1-tert.butylamino-2,3-dihydroxy-propane is obtained from ethyl acetate/ether (2:1) in the form of crystals having a M.P. of 76-81. [alpha] 20546 = -11.8 (c = 2.0; methanol). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzaldehyde; In water; benzene; | b. 22 g of <strong>[30315-46-9](S)-1-tert.butylamino-2,3-dihydroxypropane</strong>, 20.7 g of benzaldehyde and 46 cc of benzene are heated at reflux in a water separator for 16 hours. The benzene and benzaldehyde are removed by distillation and the residue is distilled in a high vacuum. (S)-3-tert. butyl-5-hydroxy-methyl-2-phenyloxazolidine is obtained as yellowish oil (B.P. 110-125 at 0.01 mm of Hg); [alpha]20546 = 17.8 (c = 1.99; chloroform). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In isopropyl alcohol; at 20 - 70℃; | General procedure: To a solution of racemic acid 1 (5.68 mg, 0.04 mmol, 1 equiv) in IPA (0.2 mL, 0.2 M) was added the chiral base (0.04 mmol, 1 equiv as a 0.2 M stock solution in IPA). The resulting mixture was heated at 70 C for 15 min to solubilize all the solids, and then allowed to cool naturally to ambient temperature with stirring overnight. Overall, 23 precipitates were obtained from the 80 combinations. The enantiomeric excess of the solid precipitate and the liquor for each reaction was analyzed by SFC. |
[ 6579-55-1 ]
1-((2-Hydroxyethyl)amino)propan-2-ol
Similarity: 0.75
[ 623-57-4 ]
3-(Dimethylamino)-1,2-propanediol
Similarity: 0.73
[ 64431-96-5 ]
2,2'-(Propane-1,3-diylbis(azanediyl))bis(2-(hydroxymethyl)propane-1,3-diol)
Similarity: 0.71
[ 34004-36-9 ]
2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride
Similarity: 0.70
[ 67622-86-0 ]
2-Methyl-1-(methylamino)propan-2-ol
Similarity: 0.69
[ 6579-55-1 ]
1-((2-Hydroxyethyl)amino)propan-2-ol
Similarity: 0.75
[ 623-57-4 ]
3-(Dimethylamino)-1,2-propanediol
Similarity: 0.73
[ 64431-96-5 ]
2,2'-(Propane-1,3-diylbis(azanediyl))bis(2-(hydroxymethyl)propane-1,3-diol)
Similarity: 0.71
[ 34004-36-9 ]
2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride
Similarity: 0.70
[ 6579-55-1 ]
1-((2-Hydroxyethyl)amino)propan-2-ol
Similarity: 0.75
[ 623-57-4 ]
3-(Dimethylamino)-1,2-propanediol
Similarity: 0.73
[ 64431-96-5 ]
2,2'-(Propane-1,3-diylbis(azanediyl))bis(2-(hydroxymethyl)propane-1,3-diol)
Similarity: 0.71
[ 34004-36-9 ]
2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride
Similarity: 0.70
[ 67622-86-0 ]
2-Methyl-1-(methylamino)propan-2-ol
Similarity: 0.69